Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
For multiple instrument reporting options, see the Quality Cross Check program, COVSQ.
- Three 0.5‐mL serum specimens
- Appropriate for assays that detect antibodies to nucleocapsid, spike, combined antigen (nucleocapsid and spike), and the receptor binding domain of the spike protein
- Shipment A: June 13
- Shipment B: November 7